Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for MYGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -2.80M
March 31, 2026 0.00
December 31, 2025 -0.60M
September 30, 2025 0.00
June 30, 2025 -2.70M
March 31, 2025 0.00
December 31, 2024 -2.90M
September 30, 2024 0.00
June 30, 2024 -3.00M
March 31, 2024 0.00
December 31, 2023 -6.00M
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 -2.40M
September 30, 2022 -0.90M
June 30, 2022 -2.70M
March 31, 2022 -0.30M
December 31, 2021 -1.80M
September 30, 2021 -39.90M
June 30, 2021 -23.60M
March 31, 2021 -26.50M
June 30, 2020 -2.00M
March 31, 2020 -0.20M
December 31, 2019 -1.70M
Date Value
September 30, 2019 0.40M
June 30, 2019 -2.20M
March 31, 2019 -2.00M
December 31, 2018 47.60M
September 30, 2018 -2.10M
June 30, 2018 -18.70M
March 31, 2018 -11.90M
December 31, 2017 -4.60M
September 30, 2017 -1.70M
June 30, 2017 -4.70M
March 31, 2017 -0.30M
December 31, 2016 7.40M
September 30, 2016 23.20M
June 30, 2016 46.30M
March 31, 2016 44.00M
December 31, 2015 -37.20M
September 30, 2015 15.20M
June 30, 2015 40.39M
March 31, 2015 56.55M
December 31, 2014 53.23M
September 30, 2014 30.53M
June 30, 2014 48.08M
March 31, 2014 1.096M
December 31, 2013 72.24M
September 30, 2013 101.52M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Natera, Inc. -17.30M
Sera Prognostics, Inc. -0.14M
BioRestorative Therapies, Inc. -4.441M
CareDx, Inc. 9.481M
Exagen, Inc. 0.00